NASH-associated gut microbiome in human microbiota-associated NAFLD mouse model
Nonalcoholic fatty liver disease (NAFLD) is a forthcoming epidemic that is currently the leading cause of chronic liver disease worldwide. By 2030, it is projected to become the primary indication for liver transplantation. Yet, there is still inconsistency and lack of conclusive evidence regardi...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/166533 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Nonalcoholic fatty liver disease (NAFLD) is a forthcoming epidemic that is currently
the leading cause of chronic liver disease worldwide. By 2030, it is projected to
become the primary indication for liver transplantation. Yet, there is still
inconsistency and lack of conclusive evidence regarding specific gut microbial
communities contributing to disease pathogenesis and how they can be manipulated
to alter disease susceptibility and progression. Therefore, this study characterized
gut microbiota changes following NAFLD onset, using a humanized diet-induced
NAFLD murine model. We first validated the significant impacts of dietary habits on
the humanized gut microbiome during nonalcoholic steatohepatitis (NASH)
development, and proved the sufficiency of fecal microbiota transplantation (FMT) in
establishing a humanized mouse gut microbiome. Subsequently, we compared the
composition and diversities of the humanized gut microbiome resulting from different
diets, revealing key microbes involved in NAFLD pathogenesis and their dynamics in
the gut microbiome. Lastly, a comparative analysis of our key findings with that of
human studies in literature demonstrated the translatability of our results to human
NAFLD. This study employed a novel method of incorporating distinct diets with
humanized gut microbiome in murine to investigate NAFLD pathogenesis, resulting
in more human-relevant findings. |
---|